Revenue
2015
2016
2017
2018
2019
2020
2021
2022
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ¥290.99B | ¥298.89B | ¥203.99B | ¥190.22B | ¥180.35B | ¥181.02B | ¥144.85B | ¥123.67B |
| Gross profit | ¥31.28B | ¥34.72B | ¥15.47B | ¥10.93B | ¥13.24B | ¥14.73B | ¥11.15B | ¥2.50B |
| Research & development | ¥4.81B | ¥2.42B | ¥1.47B | ¥940.8M | ¥626.9M | ¥498.2M | ¥168.9M | ¥168.9M |
| Operating income | ¥16.39B | ¥18.67B | ¥7.60B | ¥6.21B | ¥6.82B | — | — | — |
| EBITDAderived | ¥25.84B | ¥28.23B | ¥15.26B | ¥13.65B | ¥14.88B | — | — | — |
| Net income | ¥4.19B | ¥5.76B | ¥862.1M | ¥595.6M | ¥709.4M | ¥1.41B | ¥365.7M | ¥129.5M |
| Basic EPSper diluted share | CN¥0.24 | CN¥0.33 | CN¥0.03 | CN¥0.02 | CN¥0.03 | CN¥0.09 | CN¥0.02 | CN¥0.01 |
| Diluted EPSper diluted share | CN¥0.24 | CN¥0.33 | CN¥0.03 | CN¥0.02 | CN¥0.03 | CN¥0.09 | CN¥0.02 | CN¥0.01 |